Woodford Patient Capital Update

The demise of Neil Woodford’s fund management operation has been an upsetting episode for the company’s employees and clients alike.  Coverage suggests the saga will rumble on for some time yet but we wish to focus on the immediate impact to Woodford Patient Capital Trust, a fund established to most … Read more

Woodford Patient Capital

Nigel Moore, a senior wealth manager at Pilling & Co has been quoted in citywire.co.uk. Read the full article at: http://citywire.co.uk/investment-trust-insider/news/woodford-patient-capital-battered-shares-draw-in-bargain-hunters/a1112723 ‘The top 10 holdings now account for over 60% of the fund with significant biotech and healthcare exposure. I am concerned about the concentration effect. The long tail of 79 … Read more

Six out of 10 investors try to sell Invesco Asia

Nigel Moore, a senior wealth manager at wealth manager Pilling & Co, did not expect Invesco Asia’s discount to narrow from here – in spite of its board’s best efforts. ‘The trust’s long-term performance has been impressive yet recently it has consistently traded at or around a 10% discount to … Read more

Which Funds are Dividend Heroes?

Nigel Moore, a senior wealth manager at Pilling & Co, highlights the trust’s significant revenue reserves, which stand at approximately 13.5 pence per share. He says this equates to 85% of the full-year dividend – if the reserves were needed. “This will be advantageous to investors if corporate earnings decline … Read more